Raleigh — Raleigh, North Carolina

Raleigh is a clinical research site located in Raleigh, North Carolina, United States 27607.

Crixeo Clinical Trials Trust Score: 20/100 (FAILING). This profile has not yet been claimed by the site owner.

Raleigh has participated in 13 clinical trials with 2 currently active.

Therapeutic areas: Uterine Fibroid, Endometriosis, Endometriosis Related Pain.

Sponsors: Myovant Sciences GmbH, Sumitomo Pharma Switzerland GmbH, Oyster Point Pharma, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Raleigh

Browse all research sites in North Carolina · View every site in Raleigh

• WakeMed Health and Hospitals
• UNC Health REX Hospital
• University of North Carolina at Chapel Hill
• Duke University Medical Center
• Wake Med Health & Hospital
• University of North Carolina Urogynecology and Reconstructive Pelvic Surgery at REX
• Wake Medical Hospital
• WakeMed North Hospital
• Ohio State University-Telemedicine
• Central Regional Hospital
• University of North Carolina
• Rex Hospital

Sponsor Feasibility Report

Trust Score: 20/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Raleigh?

Raleigh has a Crixeo Trust Score of 20/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Raleigh conducted?

Raleigh has 13 clinical trials on record, with 2 currently active. Their work covers Uterine Fibroid, Endometriosis, Endometriosis Related Pain.

Is Raleigh accredited by Crixeo Clinical Trials?

Raleigh has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Raleigh?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.